Search
for
Sort by
Research 961–990 of 1000+
- Network Pharmacology Reveals Curcuma aeruginosa Roxb. Regulates MAPK and HIF-1 Pathways to Treat Androgenetic Alopecia
- Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D2 Synthase as a Multifunctional Lipocalin
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- Large-Scale Plasma Proteomics and Genetic Integration Uncover Novel Biological Pathways in Male Pattern Baldness
- Treatment options for polycystic ovary syndrome
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Polycystic ovary syndrome
- Progestogens with Antiandrogenic Properties
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Androgen Action in the Ovary
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- Towards the validation of endogenous steroid testing in wildlife hair
- Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
- The Female Pattern Hair Loss: Review of Etiopathogenesis and Diagnosis
- Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
- Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Androgenetic Alopecia: Clinical Aspects and Treatment
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Female pattern hair loss—An update
- Molecular Basis of Androgenetic Alopecia
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- Mixed Form of Hirsutism in Adolescent Females and Laser Therapy
- Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
- No. 350-Hirsutism: Evaluation and Treatment
- Quantitative analysis of 34 sex (pro)hormones, conjugates and bioactive oxidation products thereof in human plasma by GC- and LC-MS/MS and systematic investigation of overestimations of analyte concentrations not accounted for by method validation